-logo-1200x675.png){kind=logo}
Shares of CellaVision AB (publ) (OTCMKTS:CLVSF – Get Free Report) were down 25.6% during mid-day trading on Thursday . The company traded as low as $19.28 and last traded at $19.28. Approximately 157 shares traded hands during trading, a decline of 59% from the average daily volume of 383 shares. The stock had previously closed at $25.91.
CellaVision AB (publ) Price Performance
The business has a 50-day moving average price of $21.83 and a two-hundred day moving average price of $23.63.
About CellaVision AB (publ)
CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, designs to automate and simplify the process of performing blood and body fluid differentials; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears.
Read More
- Five stocks we like better than CellaVision AB (publ)
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- The Role Economic Reports Play in a Successful Investment Strategy
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- Consumer Discretionary Stocks Explained
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for CellaVision AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CellaVision AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
